| Bioactivity | α-Glucosidase-IN-13 (Compound 8) is a α-glucosidase inhibitor with an IC50 of 5.69 μM[1]. |
| Target | IC50: 5.69 μM (α-glucosidase) |
| Invitro | α-Glucosidase-IN-13 (Compound 8) forms a stable receptor–ligand complex with α-glucosidase[1]. |
| Name | α-Glucosidase-IN-13 |
| Formula | C25H28N4O3S2 |
| Molar Mass | 496.64 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Khan S A, et al. Mercaptobenzimidazole-Based 1, 3-Thaizolidin-4-ones as Antidiabetic Agents: Synthesis, In Vitro α-Glucosidase Inhibition Activity, and Molecular Docking Studies. ACS Omega, 2022. |